Skip to Content
 

News: September, 2021

We are making progress

Thursday, September 30th, 2021

At Vanderbilt-Ingram Cancer Center, we have multiple research laboratories dedicated to specific types of cancer, where investigators delve into cancer etiologies and search for better treatments. For example, a laboratory group led by Dr. Michael Savona focuses on preventing and treating blood cancers, such as leukemia and myelodysplastic syndrome. The cover story in this issue […]

Philanthropist honored

Thursday, September 30th, 2021

A gift in memory of music industry executive and community philanthropist Phran Galante will support the work of Christine Lovly, MD, PhD, associate professor of Medicine and Ingram Professor of Cancer Research, to improve targeted therapies for lung cancer. Galante was a champion for homeless pets, sick children and cancer research in her philanthropic endeavors. […]

Blood cancer patients with COVID-19 benefit from convalescent plasma

Thursday, September 30th, 2021

Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19). Patients who received convalescent plasma from donors who had recovered from COVID-19 had a death rate of 13.3% compared […]

Expedited Care

Thursday, September 30th, 2021

When people go to an emergency room after being injured, suspicious images may show up on their imaging scans that are unrelated to their injuries but may be indicative of cancer. A team at Vanderbilt University Medical Center recently established a better process for ensuring these patients receive follow-up diagnostic care, an initiative that is […]

HPV vaccine demand dips in pandemic

Thursday, September 30th, 2021

Asignificant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention. Vanderbilt-Ingram Cancer Center (VICC) is partnering with 71 other National Cancer Institute (NCI)-designated cancer centers and partner organizations to urge physicians, parents […]

Q+A: Psych-Oncology

Thursday, September 30th, 2021

Michael Radyko, PMHNP-BC, APN, LCSW, leads the Psychology-Oncology Program, which offers mental health support to cancer patients. Q Is this a new service for cancer patients? A The psychology-oncology program was launched in September 2020 after some earlier pilot initiatives. It is a joint venture between Vanderbilt Behavioral Health and Vanderbilt-Ingram Cancer Center to support […]

Journal Watch

Thursday, September 30th, 2021

People at high genetic risk for colorectal cancer benefit more from lifestyle changes People with a high polygenic risk score for colorectal cancer could benefit more by preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American […]

At the Helm

Thursday, September 30th, 2021

Art Rich is a production manager who makes big events happen — big events like Broadway plays, concert tours, corporate conferences and even Nashville’s CMA Fest. He has his eyes focused on the lighting, his ears attuned to the sound, and his scheduling of logistics perfectly organized for these events. He knows that the right […]

Fellowship Gift

Thursday, September 30th, 2021

After about a decade of treatment for the blood cancer polycythemia vera (PV), Paula Lovell’s bad days started outnumbering the good ones. She told her doctor, Michael Savona, MD, that she was “having one of my spells,” a phrase that her grandmother had used when an occasional sickness wasn’t easily explained. “I had no good […]

IMPACT grant addresses racial disparities in blood cancer discovery

Thursday, September 30th, 2021

The Leukemia & Lymphoma Society recently selected a Vanderbilt University Medical Center-led effort for one of its first IMPACT grants (Influential Medicine Providing Access to Clinical Trials). A goal of the five-year initiative is to increase clinical trial enrollment from underrepresented communities to at least 20%. Michael Savona, MD, professor of Medicine at VUMC, is […]

Next Page »